SINGULAIR - 24236-860-19 - (montelukast sodium)

Alphabetical Index


Drug Information of SINGULAIR

Product NDC: 24236-860
Proprietary Name: SINGULAIR
Non Proprietary Name: montelukast sodium
Active Ingredient(s): 10    mg/1 & nbsp;   montelukast sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of SINGULAIR

Product NDC: 24236-860
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020829
Marketing Category: NDA
Start Marketing Date: 20130328

Package Information of SINGULAIR

Package NDC: 24236-860-19
Package Description: 90 TABLET, FILM COATED in 1 CANISTER (24236-860-19)

NDC Information of SINGULAIR

NDC Code 24236-860-19
Proprietary Name SINGULAIR
Package Description 90 TABLET, FILM COATED in 1 CANISTER (24236-860-19)
Product NDC 24236-860
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name montelukast sodium
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130328
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name MONTELUKAST SODIUM
Strength Number 10
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of SINGULAIR


General Information